Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

This article discusses literally a couple dozen vaccines and drugs that are in development for Ebola.  How is their testing being fast-tracked ?

 2013 Dec;27(6):565-83. doi: 10.1007/s40259-013-0046-1.
Choi JH1, Croyle MA.

Abstract

Ebola is a highly virulent pathogen causing severe hemorrhagic fever with a high case fatality rate in humans and non-human primates (NHPs). Although safe and effective vaccines or other medicinal agents to block Ebola infection are currently unavailable, a significant effort has been put forth to identify several promising candidates for the treatment and prevention of Ebola hemorrhagic fever. Among these, recombinant adenovirus-based vectors have been identified as potent vaccine candidates, with some affording both pre- and post-exposure protection from the virus. Recently, Investigational New Drug (IND) applications have been approved by the US Food and Drug Administration (FDA) and phase I clinical trials have been initiated for two small-molecule therapeutics: anti-sense phosphorodiamidate morpholino oligomers (PMOs: AVI-6002, AVI-6003) and lipid nanoparticle/small interfering RNA (LNP/siRNA: TKM-Ebola). These potential alternatives to vector-based vaccines require multiple doses to achieve therapeutic efficacy, which is not ideal with regard to patient compliance and outbreak scenarios. These concerns have fueled a quest for even better vaccination and treatment strategies. Here, we summarize recent advances in vaccines or post-exposure therapeutics for prevention of Ebola hemorrhagic fever. The utility of novel pharmaceutical approaches to refine and overcome barriers associated with the most promising therapeutic platforms are also discussed.

Similar Posts

Opinion: Americans will increasingly have to make their own judgments about covid-19 risks/WaPo

OMG, the WaPo has published an article that simply makes sense about masking.  CDC just admitted the truth, after 14 months, that aerosol transmission of Covid is a ‘thing.’ CDC’s pivot to the truth, I fear, may be intended to force us to move to N95 masks–a move that has been floated in Europe for…

What if the former CDC director is right about the Wuhan labs?/ WaPo

Surprise!  Finally, a clear, non-partisan way forward, to face facts, and honestly investigate the origin of SARS-CoV-2 and the Covid pandemic.  Josh Rogin explains in a WaPo Opinion how to rethink the origins narrative.  And he quotes Nicolai Petrovsky in Australia to inform us that we really need a rethink about all the “gain of…

Pharmaceutical firm spied on top FDA official/ Politico and Mercola.com

From Politico, this story of how over $100,000 was spent to dig up dirt on the head of FDA’s Center for Drug Evaluation and Research: For more than two months in late 2008, private investigators working for a drug company gathered information on a high-ranking official at the Food and Drug Administration — unearthing details about…

U.S. nuclear missile base (50 nuclear missiles) loses communication with Washington/CBC

From Canadian Broadcasting:   “A computer failure caused a break in communication with 50 nuclear missiles at Warren Air Force Base in Wyoming during the weekend, military officials said Tuesday.”  The military did not see fit to inform the President until today, 3 days after the incident.  You didn’t really think Obama was running this…

One Comment

Comments are closed.